| Date Posted |
Subject |
| Dec. 31, 2002 |
Do FDA recommendations regarding deferral of donations by recent recipients of smallpox vaccine apply to persons wishing to make an autologous donation? ADDENDA Jan. 3 & 6, 2003 |
| Dec. 30, 2002 |
Improving the process of patient identification - 2003 update ADDENDA Jan. 8, 2006 |
| Dec. 30, 2002 |
Antibody identification using ficin-treated red cells and a PEG enhancement medium ADDENDA Jan. 3 & 10, 2003 |
| Dec. 29, 2002 |
Policies for managing donors and blood products in countries endemic for malaria ADDENDA Dec. 30 |
| Dec. 12, 2002 |
How do hospital Transfusion Services validate the integrity of blood products transported in a Pneumatic Tube System? |
| Dec. 12, 2002 |
How do Transfusion Services investigate blood components suspected of causing bacterial sepsis in recipients? |
| Dec. 10, 2002 |
Should automatic external defibrillators (AED) be available in the donor collection setting (esp. at mobile sites)? ADDENDA Dec. 12, 13, 17 & 18; June 29 & 30; July 1, 2003 |
| Dec. 5, 2002 |
Should pre-transfusion ABO/Rh testing be performed twice, and if so, on different samples or by different personnel? ADDENDA Dec. 6, 9, 10, 12 & 20; Jan. 8 & 9, 2003; July 20, 26, 28, Aug. 3, 10, 15, 24 & 26, 2004; Dec 28 & 31, 2004; Jan 24, May 3, 4, 8, 10, 11 & 14, 2005; Sept. 21 & 29, 2006 |
| Dec. 4, 2002 |
2,3-DPG
kits and reagents needed for red cell storage
studies ADDENDA Dec.
11, 2002; Jan. 9, 17, 21 & 27; Feb. 5 & May 6, 2003; Apr.
8, 2006; Nov. 13, 2007 |
| Dec. 1, 2002 |
What are best practices for building a frozen serum repository of blood donor samples for possible future infectious agent testing? ADDENDA Dec. 2, 3, 8 & 9 |
| Nov. 26, 2002 |
Emergency release and who can sign for untested or uncrossmatched blood ADDENDA Nov. 27 & Dec. 5 & 13 |
| Nov. 23, 2002 |
Alternatives to bleach for disinfecting equipment and countertops ADDENDA Dec. 8 |
| Nov. 21, 2002 |
How do colleagues test for and report Rh typing results of individuals who are weak D positive? |
| Nov. 16, 2002 |
When the supernatant of a red cell unit shows visible discoloration suggesting hemolysis, should it be issued for transfusion? ADDENDA Nov. 20, 2002; Oct 28, 2004; May 30, 2007; Mar. 4, 2008 |
| Nov. 13, 2002 |
Is it acceptable practice to administer multiple blood products simultaneously to a patient? ADDENDA Nov. 14 & 20 |
| Nov. 13, 2002 |
Ensuring proper blood storage and patient identification in ambulatory surgery centers lacking onsite laboratory support ADDENDA Dec. 11 |
| Nov. 12, 2002 |
Prestorage leukoreduction for prevention of transfusion-transmitted CMV infection - current AABB recommendations |
| Nov. 9, 2002 |
Experience with benchmarking data to improve local practices in transfusion medicine |
| Nov. 8, 2002 |
A case report of the mysterious development of anti-D in pregnancy ADDENDA Nov. 12 & 13; Mar. 25 & 27, 2003 |
| Nov. 8, 2002 |
Red cells for neonates on ECMO - Questions about the study by Eder et al. suggesting that additive RBC are as safe as CPD/A RBC |
| Nov. 7, 2002 |
Reimbursement for the computer crossmatch procedure - re-revisited (from Aug. 29, 2002) |
| Nov. 6, 2002 |
What is the risk that a blood donation might cause transmission of Lyme Disease? ADDENDA Nov. 10, 2002; Aug. 13, 2003 |
| Nov. 5, 2002 |
Status of automated red cell exchanges (ARBCx) as a treatment modality in sickle cell disease ADDENDA Nov. 7 & 8 |
| Nov. 4, 2002 |
Platelet transfusions during cardiothoracic surgery ADDENDA Nov. 26 & Dec. 6 |
| Nov. 2, 2002 |
Management of thrombocytopenia associated with therapeutic plasma exchange (TPE), when the thrombocytopenia is believed to be heparin-induced ADDENDA Nov. 4 & 5 |
| Oct. 31, 2002 |
Should sickle cell trait individuals be eligible to make plateletpheresis donations? |
| Oct. 29, 2002 |
Are concerns about recent aspirin ingestion by whole blood donors justified? ADDENDA Oct. 30 & 31 |
| Oct. 27, 2002 |
Should RBCs used for intrauterine transfusion be washed and/or adjusted to a high Hct? ADDENDA Oct. 28 & 30 |
| Oct. 24, 2002 |
What are the upper and lower hemoglobin/hematocrit levels used by blood collection centers to decide when to refer a donor for further medical evaluation? |
| Oct. 22, 2002 |
Does the Joint Commission for Accreditation of Healthcare Organizations (JCAHO) require hospitals to have a Transfusion Committee? ADDENDA Jan. 8, 2006 |
| Oct. 22, 2002 |
Should a test for fetomaternal hemorrhage (FMH) be done before administering Rh Immune Globulin to Rh-negative women at risk of FMH in early pregnancy? ADDENDA Oct. 23; Oct. 7, 26 & 28, 2005 |
| Oct. 11, 2002 |
Unexpected red cell alloantibodies detected in SERUM but not in PLASMA ADDENDA Oct. 14 |
| Oct. 9, 2002 |
Transfusion practices during and after reinfusion of blood salvaged during surgery |
| Oct. 8, 2002 |
Methods used to screen blood donors for anemia ADDENDA Oct. 19; UPDATE Nov. 19 |
| Oct. 1, 2002 |
Donor deferral following widespread smallpox vaccination ADDENDA Oct. 2 & 3, Nov. 26; Jan 31, 2005 |
| Sept. 30, 2002 |
What are the personnel
requirements for hanging blood components and
signing off on the transfusion records? ADDENDA Nov. 7, 2007 |
| Sept. 25, 2002 |
Should we worry about cold-reacting antibodies in patients undergoing hypothermia for cardiac surgery? (REVISITED) ADDENDA Nov. 21 & 26, Dec. 15; May 22, June 2 & Sept. 22, 2003; Sept 30, 2004; May 26, 2005 |
| Sept. 24, 2002 |
Improving the process of patient identification and specimen tube labeling ADDENDA Sept. 25 & 26 |
| Sept. 19, 2002 |
Reconciling concerns about volume overload in sensitive neonates with the regulatory requirement to complete blood infusions within 4 hours ADDENDA Sept. 20 & 26 |
| Sept. 18, 2002 |
Using automatic IV infusion pumps for the transfusion of red cells ADDENDA Sept. 19 & 22 |
| Sept. 13, 2002 |
Is Rh Immunoglobulin (RhIG) necessary when platelets from Rh-incompatible donors are given to females of child-bearing potential? |
| Sept. 12, 2002 |
Monitoring temperature of blood products transported within the hospital ADDENDA Sept. 14, 16 & 18; May 12, 22 & 24, 2006; Feb. 5 & 15, 2007 |
| Sept. 11, 2002 |
Is an attending
physician's countersignature required for transfusion consent
forms? ADDENDA Sept. 12 & 18;
Jan. 29, 2008 |
| Sept. 9, 2002 |
Overriding a patient's request to refuse transfusion ADDENDA Sept. 10, 16 & 17 |
| Sept. 7, 2002 |
Is Interleukin-11 of value in raising the platelet count in surgical patients (Jehovah's Witnesses) with thrombocytopenia? ADDENDA Sept. 11 & Nov. 15 |
| Sept. 5, 2002 |
Should perfusionists in the operating room be allowed to administer units of blood? ADDENDUM Sept. 9 |
| Sept. 4, 2002 |
Alternatives to commercial ficin for treating red cells for allogeneic adsorption ADDENDUM Sept. 6 |
| Aug. 29, 2002 |
Problem with California State Donor Deferral File of Aug 1, 2002 |
| Aug. 29, 2002 |
Transfusion medicine leaders urge blood collection community to immediately initiate program to detect bacteria in platelet products ADDENDA Aug. 30, Sept. 4, 6, 11, 13 & 16; Mar. 10, 2003 |
| Aug. 29, 2002 |
How do you deal with competing patient demands for blood? REACTIVATED May 9, 2004; ADDENDA May 12, 13 & 17, 2004 |
| Aug. 29, 2002 |
Reimbursement for the computer crossmatch procedure - revisited; ADDENDA Apr. 20, 22, 25; Nov. 17 & 21, 2005; Jan. 24 & Feb. 13, 2006 |
| Aug. 27, 2002 |
Is routine donor screening for unexpected antibodies really necessary? |
| Aug. 16, 2002 |
Should one offer Rh immunoprophylaxis for a woman who delivers a baby determined to be Dvi positive? ADDENDA Aug. 17 & 28 |
| Aug. 15, 2002 |
What is the current required lookback period for a donor testing confirmed positive for HIV-1 p24 antigen only? ADDENDA Aug. 16 |
| Aug. 9, 2002 |
West Nile Virus and the US Blood Supply ADDENDUM Sept. 15; UPDATED July 25, 2005 |
| Aug. 8, 2002 |
Improved Methods for Quantitating Fetal-Maternal Hemorrhage ADDENDA Aug. 9; Jan. 12, 2005 |
| Aug. 7, 2002 |
Should cellular blood products for exchange transfusion in neonates be routinely irradiated? ADDENDA Aug. 8 |
| Aug. 6, 2002 |
What do you say to a non-blood banker pathologist who thinks the discipline of transfusion medicine is static? |
| Aug. 2, 2002 |
Should brain-dead persons whose organs qualify for harvesting and transplantation receive red cell transfusions to improve organ survival? ADDENDA Mar. 28, 2005 |
| Aug. 1, 2002 |
What studies should be done to validate a new antiseptic before using it for arm preparation of blood donors? ADDENDA Dec. 28, 29 & 30, 2003 |
| July 30, 2002 |
Reactions due to hypersensitivity to latex or thiuram in transfusion recipients |
| July 28, 2002 |
Unexplained Positive Direct Antiglobulin Test (DAT) results in both pre- and post-transfusion specimens associated with a febrile reaction to transfusion ADDENDUM July 29 |
| July 11, 2002 |
Selection of Red Cells for supporting Rh-positive recipients of Rh-negative marrow during and after engraftment ADDENDA July 13 |
| June 28, 2002 |
Acceptable containers for temporary storage of blood in the operating room and ICU ADDENDA June 28 & July 2 |
| June 24, 2002 |
When to use volume-reduced blood products for avoiding volume overload in patients at risk? ADDENDA June 24 |
| June 21, 2002 |
Managing irradiated Red Cell inventory to prevent release of older units to patients at risk of hyperkalemia ADDENDA June 25 |
| June 16, 2002 |
Could there be a link between blood transfusions and atherosclerosis? ADDENDA Jan. 8, 2006 |
| June 14, 2002 |
Antibody titer studies in pregnant women at risk for bearing an infant with hemolytic disease of the newborn ADDENDA June 18 & 19; May 7, 10 & 16, 2008 |
| June 13, 2002 |
Warm autoantibody-adsorption procedures with PEG ADDENDA Jan 9, 2005 |
| June 12, 2002 |
Recommendations for storage of RHIG (Rh Immune Globulin) ADDENDA June 13 & 14 |
| June 11, 2002 |
Should at-risk donors be interviewed and/or tested for T. cruzi infection to prevent transfusion-transmitted Chagas Disease? ADDENDA June 12 & 21; July 11; Aug. 1; Sept. 3; Nov 29 & 30, 2004; Feb. 19, 21 & 24, 2007 |
| June 10, 2002 |
Prospective donors with rheumatoid arthritis, multiple sclerosis, ulcerative colitis, Crohn's disease, a history of Guillain-Barre syndrome ADDENDA June 11 REACTIVATED with ADDENDA Jan. 8, 2004 |
| June 2, 2002 |
Pediatric Transfusion Guidelines - A Resource ADDENDUM June 5 |
| June 1, 2002 |
Crossmatching pediatric patients over age 4 months of age in anticipation of large volume operative and post-op blood loss ADDENDUM June 3 |
| May 31, 2002 |
Updated information regarding 'Blood Substitutes' ADDENDA June 3 & 10 |
| May 30, 2002 |
Emergency reversal of Warfarin effect - FFP or Prothrombin Complex Concentrate? ADDENDA May 31; Jan. 5, 6, 8, 9, 10, 13, 15, 17 & 24, 2006 |
| May 29, 2002 |
Validating igloo coolers that are used to 'store' blood in the operating room ADDENDA Feb. 7, 2007 |
| May 28, 2002 |
Maintaining patency of intravenous lines between repeated therapeutic hemapheresis procedures ADDENDA May 29 & June 8 |
| May 23, 2002 |
Transfusion support with RBC and plateletpheresis units for patients who are post auto/-allo BMT or solid organ transplantation ADDENDA May 24 |
| May 22, 2002 |
Screening for sickle cell trait and informing blood donors of the test results |
| May 21, 2002 |
Questions about the use of blood component recipient sets ADDENDUM May 28 |
| May 16, 2002 |
Infusing drugs or IV solutions along with blood ADDENDA May 17, 20, 21, 22 & 23; Dec. 30, 2005; June 4, 2006 |
| May 15, 2002 |
Documentation that blood has been transfused ADDENDUM May 17 |
| May 12, 2002 |
Transfusions that exceed four hours in duration ADDENDA May 13 |
| May 12, 2002 |
Labeling specimens that may lead to compatibility testing RESPONSE May 23 |
| May 10, 2002 |
The practice of transfusing out-of-type platelets ADDENDA May 11, 13 & 14; Sept. 2, 8, 20 & 29; Oct. 3, Nov. 1 & 2, 2005 |
| May 9, 2002 |
Use of Type and Screen versus NO pre-operative blood orders for a patient who has a scheduled elective surgical procedure with a low likelihood of requiring blood transfusion ADDENDA May 14, 15, 17 & 20 |
| May 6, 2002 |
Neonatal transfusion practices ADDENDUM May 14 |
| May 3, 2002 |
RBC transfusions for a patient with ITP who is receiving IV anti-D therapy ADDENDA May 3, 6 & 7 |
| May 1, 2002 |
Transfusing donor
RBC units obtained from individuals whose plasma
contains unexpected antibodies ADDENDA May
2; Feb. 21, 2007; May 16 & June 25, 2008 |
| April 30, 2002 |
How often should one repeat the antibody identification panel workup for a patient who is known to be alloimmunized? ADDENDA May 1, 2, 5, 8 & 9 |
| April 28, 2002 |
Informing patients when pre-transfusion testing shows that their blood contains red cell antibodies ADDENDA April 29; June 8, 9, 12 & 16, 2006 |
| April 23, 2002 |
Resolving Rh status of a newborn infant whose direct antiglobulin test is positive |
| April 21, 2002 |
Transfusion-Related
Acute Lung Injury (TRALI) (REACTIVATED April
29, 2003) - a Serious and Under-recognized Complication
of Transfusion. ADDENDA April
23, 24 & May 10, 2002; Mar. 19, 2008 |
| April 16, 2002 |
Are single unit red cell transfusions still considered 'suboptimal care'? ADDENDUM April 17 |
| April 15, 2002 |
Calibrating Digital Timers ADDENDA April 16 & 22 |
| April 13, 2002 |
Is it a safe practice to transfuse sickle trait donor RBC units to patients with sickle cell disease? |
| April 12, 2002 |
Does your hospital have a problem with STAT pre-transfusion testing orders for elective scheduled surgery? ADDENDUM April 13 & 16, Dec. 30 & 31, 2005; Jan. 2, 5 & 8, 2006 |
| April 9, 2002 |
Should transfusion of thalassemia patients be managed using phenotype-matched RBC donor units? ADDENDUM April 15 |
| April 8, 2002 |
What is an appropriate way for institutions to assure patient identification? ADDENDA April 11, 2002; Feb. 24 & 25, Mar. 2 & 5, 2006 |
| April 8, 2002 |
Benchmark for blood use in open heart and valve replacement surgeries RESPONSES April 10 ADDENDUM April 11 |
| April 6, 2002 |
Concern over non-confirming reactive or false positive disease marker results |
| April 4, 2002 |
Deferral from blood donation of individuals who received human growth hormone |
| April 4, 2002 |
Using a microwave
to thaw FFP ADDENDA Sept. 21, 2007 |
| April 3, 2002 |
A call for "benchmark" data for peer review of blood utilization ADDENDA April 4 & 5; Mar 23, 29 & April 6, 2005 |
| April 2, 2002 |
Reducing supernatant plasma of pooled platelets before administration to ABO-incompatible adult recipients ADDENDA April 3, 8 & 14 |
| Mar. 29, 2002 |
Chagas Disease Found in Three Organ Transplant Recipients - Priorities for testing blood donors? |
| Mar. 21, 2002 |
Factor V inhibitors are a complication of bovine thrombin exposure |
| Mar. 20, 2002 |
Transporting patient-assigned blood products between hospitals |
| Mar. 18, 2002 |
Case report of a pediatric patient who received a transfusion of a pool of four platelet concentrates and experienced rigors and a rise in temperature to 40C ADDENDA Mar. 18 |
| Mar. 12, 2002 |
Documenting disposal of blood removed by therapeutic phlebotomy ADDENDUM Mar. 13 |
| Mar. 5, 2002 |
Monitoring frequent platelet pheresis donors for developing thrombocytopenia ADDENDA Mar. 6 |
| Mar. 5, 2002 |
Using pH paper to QC platelets ADDENDA Mar. 7 & 11 |
| Feb. 28, 2002 |
Relabeling thawed FFP as thawed plasma ADDENDUM Mar. 5, 2002; Dec. 16, 21 & 26, 2006 |
| Feb. 26, 2002 |
Use of expired reagent panel cells ADDENDA Feb. 27 & 28 |
| Feb. 20, 2002 |
Experience with OVERLY irradiated blood products? RESPONSE April 16 |
| Feb. 20, 2002 |
Monitoring FFP for inadvertent thawing and refreezing ADDENDA Feb. 21 & 24 |
| Feb. 12, 2002 |
Are concerns over adhesive leaching through a blood bag justified? ADDENDA Feb. 16 & 25, Mar. 5 |
| Feb. 12, 2002 |
How important is it to avoid Rh mismatched platelets for Rh-negative female neonates? ADDENDA Feb. 16 & 17, Mar. 13 & 15 |
| Feb. 10, 2002 |
Getting paid when you do the computer crossmatch procedure ADDENDA Mar 27, April 3 & 6 |
| Feb. 6, 2002 |
Do tube stoppers or stopper byproducts cause crossmatch interferences? |
| Feb. 3, 2002 |
Guidance on the length of time a patient must be observed during the start of a transfusion ADDENDUM Feb. 6 |
| Jan. 30, 2002 |
Preventing pre-transfusion specimen labeling errors ADDENDA Jan 30 & 31, Feb. 3; June 20, 21 & Nov. 12, 2006 |
| Jan. 27, 2002 |
How often should blood administration sets be changed while a patient is being transfused? ADDENDA May 16, 17 & 18, 2004 |
| Jan. 22, 2002 |
Transfusion of patients who have paroxysmal nocturnal hemoglobinuria (PNH) ADDENDUM Jan. 24 |
| Jan. 19, 2002 |
Febrile transfusion reactions and/or rigors with almost EVERY platelet transfusion ADDENDA Jan. 20 & 23 |
| Jan. 16, 2002 |
Recognition of patients who need special cellular products that are washed, irradiated, leukocyte-reduced and/or CMV negative ADDENDA Jan. 17, 21 & 30 |
| Jan. 12, 2002 |
Hemolysis while 'processing' irradiated directed donor RBC units via a cell saver in the operating room ADDENDUM Jan. 13 |
| Jan. 6, 2002 |
X-ray examination of blood products as a security measure at the time of their delivery ADDENDA Jan. 7 & 10 |
|
